Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Transversus Abdominis Plane Blocks With Abdominoplasty (TAPA)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2011 by Clinique Saint-Jean, Bruxelles.
Recruitment status was:  Not yet recruiting
Information provided by:
Clinique Saint-Jean, Bruxelles Identifier:
First received: January 14, 2011
Last updated: April 26, 2011
Last verified: February 2011
Comparing morphine consumption and recovery with two different TAP block techniques after abdominoplasty.

Condition Intervention Phase
Post Operative Pain
Drug: Ropivacaine 0.25%, 0.5 ml/kg
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Prevention
Official Title: Transversus Abdominis Plane Blocks in Patients Scheduled for an Abdominoplasty. A Prospective, Randomized, Double Blind, Comparison Between the Posterior Approach and Placebo.

Further study details as provided by Clinique Saint-Jean, Bruxelles:

Primary Outcome Measures:
  • Morphine consumption [ Time Frame: 48 hours ]
    Consumption measured by the use of the PCA pump

Secondary Outcome Measures:
  • VAS score [ Time Frame: 48 hours ]
  • Post operative nausea and vomiting [ Time Frame: 48 hours ]
  • Constipation [ Time Frame: 48 hours ]
  • Pruritus [ Time Frame: 48 hours ]
  • First time to get up [ Time Frame: 48 hours ]
  • First time to eat [ Time Frame: 48 hours ]

Estimated Enrollment: 60
Study Start Date: June 2011
Estimated Study Completion Date: August 2012
Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: iTAP-group
Posterior approach for TAP: ultrasound guided bilateral needle insertion in the transversus abdominis plane, anterior to the quadratus lumborum muscle
Drug: Ropivacaine 0.25%, 0.5 ml/kg
Posterior approach for TAP: ultrasound guided bilateral needle insertion in the transversus abdominis plane, anterior to the quadratus lumborum muscle
Active Comparator: aTAP-group
Subcostal approach for TAP: US guided needle insertion in the transversus abdominis plane, lateral to rectus sheet
Drug: Ropivacaine 0.25%, 0.5 ml/kg
Subcostal approach for TAP: US guided needle insertion in the transversus abdominis plane, lateral to rectus sheet

Detailed Description:
TAP blocks have the potential to become an important part of multi-modal analgesia after abdominal surgery (1,2). Originally Dr J McDonnell described a blind double pop technique, trough the triangle of Petit, with up to 48 hours of analgesia (3,4). Dr P Hebbard described an ultrasound based technique with a subcostal (for supra-umbilical analgesia) and an axillary mid-line injection (for sub-umbilical analgesia) in the TAP, with reported analgesia for up to 8 hours (5,6). Recently Dr J McDonnell presented data showing para vertebral spread (up to L5) of the (high dose, low concentration) local anaesthetic explaining the prolonged analgesic effect (7,8). In 2007 Dr Blanco described an ultrasound guided technique for the posterior infiltration as performed by McDonnell (9). Our limited observational comparison between both block techniques confirms this difference. We decided to compare both techniques (the ultrasound guided single shot subcostal injection, the aTAP-group (Hebbard is from Australia) and the ultrasound guided posterior injection, the iTAP-group (McDonnell is from Ireland). We will use the same volume and concentration of local anesthetic and we will asses their analgesic efficacy and improvement in quality of recovery.

Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Eligible for abdominoplasty
  • ASA 1-2
  • Fluent french/dutch/english

Exclusion Criteria:

  • History of allergy to local anaesthetics
  • Chronic opioids abuse
  • Pregnant patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01278264

Contact: Arnaud G Bosteels, MD 02 221 97 62 ext 0032

Clinique Saint Jean Not yet recruiting
Bruxelles, Belgium, 1000
Principal Investigator: Arnaud G Bosteels, MD         
Sponsors and Collaborators
Clinique Saint-Jean, Bruxelles
Principal Investigator: Arnaud G Bosteels, MD Clinique Saint-Jean, Bruxelles
  More Information

6. McDonnell J. XXIX Annual ESRA congress - Porto, Portugal, 2010.
7. Blanco R. TAP block under ultrasound guidance: the description of a
5. McDonnell J. Ultrasound guided abdominal wall blocks. X Annual BARA meeting -Brussels, Belgium, 2010
4.O'Donnell BD, McDonnell JG, McShane AJ. The transversus abdominis plane (TAP) block in open retropubic prostatectomy. Reg Anesth Pain Med. 2006 Jan-Feb;31(1):91. No abstract available. Erratum in: Reg Anesth Pain Med. 2006 May-Jun;31(3):286. McDonnell, John G [added]; McShane, Alan J [added]. PMID: 16418039

Responsible Party: Arnaud G Bosteels, Service Anesthesie Clinique Saint-Jean Bruxelles Identifier: NCT01278264     History of Changes
Other Study ID Numbers: ANESAB001
Study First Received: January 14, 2011
Last Updated: April 26, 2011

Keywords provided by Clinique Saint-Jean, Bruxelles:
Transversus abdominis plane block
Ultrasound guided

Additional relevant MeSH terms:
Pain, Postoperative
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents processed this record on May 25, 2017